相关实验视频

Updated: Jul 10, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

对不同病理类型的子宫内膜癌的临床特征和预后进行比较:一项以人口为基础的回顾性研究

Gong Zhang¹, Fangfang Nie², Weinan Zhao³

¹Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

World journal of surgical oncology

|November 21, 2023

概括

这项研究揭示了各种子类型的子宫内膜癌 (EC) 中临床特征和预后的显著差异. 子宫内膜腺癌 (UEC) 通常显示出较好的预后相比较罕见的类型,如子宫清细胞癌 (UCCC) 和子宫血清癌 (USC).

科学领域:

妇科瘤学妇科瘤学
病理学病理学病理学
临床研究临床研究

背景情况:

子宫内膜癌 (EC) 是一种流行的妇科恶性瘤,其病理亚型之间的区别不清楚.
了解这些差异对于准确的诊断和治疗计划至关重要.

研究的目的:

以回顾分析不同类型的子宫内膜癌的病理学特征和预后因素.
为了比较子宫内膜腺癌 (UEC),子宫血清癌 (USC),子宫混合癌 (UMC) 和子宫清细胞癌 (UCCC) 的整体存活率 (OS) 和无进展存活率 (PFS).

主要方法:

州大学第一附属医院的570名EC患者的回顾性分析.
利用单变量/多变量考克斯模型来确定预后因素.
OS和PFS分别是主要和次要终点.

主要成果:

这项研究包括396例UEC,106例USC,34例UMC和34例UCCC病例.
与其他亚型相比,UEC患者更年轻,早期阶段,更年期和淋巴结转移率较低.
与UEC相比,UCCC和USC的OS和PFS明显较差. 早期的UCCC患者和晚期的USC患者的治疗结果较差. 没有或仅接受化疗的UCCC患者的生存状况更差.

结论:

在UEC和更罕见的EC类型之间,基线特征存在显著差异.
EC亚型的预后影响受临床瘤阶段和治疗策略的影响.
基于病理类型和阶段的量身定制的治疗方法对于改善患者的结果至关重要.

关键词:

宫内膜癌 (Endometrial carcinoma) 是一种子宫内膜癌.预测预后预测预测在子宫清晰细胞癌.子宫内膜腺癌子宫内膜腺癌.子宫血清性癌,子宫混合性癌.

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

相关概念视频

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...